表紙
市場調查報告書

胰島素幫浦:醫療設備的開發平台評估

Insulin Pumps - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 357839
出版日期 內容資訊 英文 203 Pages
訂單完成後即時交付
價格
Back to Top
胰島素幫浦:醫療設備的開發平台評估 Insulin Pumps - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年07月05日內容資訊: 英文 203 Pages
簡介

本報告提供胰島素幫浦相關之開發中產品調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的近幾年趨勢等資訊。

第1章 目錄

第2章 簡介

  • 胰島素幫浦概要

第3章 開發中的產品

  • 胰島素幫浦 - 開發中產品:各開發階段
  • 胰島素幫浦 - 開發中產品:各市場區隔
  • 胰島素幫浦 - 開發中產品:各地區 (國家)
  • 胰島素幫浦 - 開發中產品:各法規途徑
  • 胰島素幫浦 - 開發中產品:各核准時期 (估計)
  • 胰島素幫浦 - 持續中臨床實驗

第4章 胰島素幫浦 - 正在開發的開發中產品:各企業

  • 胰島素幫浦企業 - 開發中產品:各開發階段
  • 胰島素幫浦 - 開發中產品:各開發階段

第5章 胰島素幫浦 開發企業與產品概要

  • Amrita Vishwa Vidyapeetham
  • Andain, Inc
  • Cellnovo Ltd.
  • CeQur SA
  • ConvaTec Healthcare B S.a.r.l.
  • Debiotech S.A.
  • Hospira, Inc.
  • Insulet Corporation
  • InsuLine Medical Ltd.
  • LifeScan, Inc.
  • MedSolve Technologies, Inc.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NanoMed Ltd
  • Phluid Corporation
  • Sensile Medical AG
  • SFC Fluidics LLC
  • Spring Health Solutions Ltd.
  • Tandem Diabetes Care, Inc.
  • ViCentra B.V.
  • Ypsomed Holding AG

第6章 胰島素幫浦 - 近幾年趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0784EPD

GlobalData's Medical Devices sector report, "Insulin Pumps - Medical Devices Pipeline Assessment, 2019" provides an overview of Insulin Pumps currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Pumps pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Insulin Pumps under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Insulin Pumps and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Insulin Pumps under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Insulin Pumps Overview

3 Products under Development

  • 3.1 Insulin Pumps - Pipeline Products by Stage of Development
  • 3.2 Insulin Pumps - Pipeline Products by Segment
  • 3.3 Insulin Pumps - Pipeline Products by Territory
  • 3.4 Insulin Pumps - Pipeline Products by Regulatory Path
  • 3.5 Insulin Pumps - Pipeline Products by Estimated Approval Date

4 Insulin Pumps - Pipeline Products under Development by Companies

  • 4.1 Insulin Pumps Companies - Pipeline Products by Stage of Development
  • 4.2 Insulin Pumps - Pipeline Products by Stage of Development

5 Insulin Pumps Companies and Product Overview

  • 5.1 Amrita Vishwa Vidyapeetham Company Overview
  • 5.2 Andain, Inc Company Overview
  • 5.3 Becton Dickinson and Co Company Overview
  • 5.4 Cam Med LLC Company Overview
  • 5.5 Cellnovo Ltd Company Overview
  • 5.6 Debiotech SA Company Overview
  • 5.7 Hospira Inc Company Overview
  • 5.8 Insulet Corp Company Overview
  • 5.9 LifeScan Inc Company Overview
  • 5.10 MedSolve Technologies, Inc. Company Overview
  • 5.11 Medtronic plc Company Overview
  • 5.12 MicroPort Scientific Corp Company Overview
  • 5.13 Pennsylvania State University Company Overview
  • 5.14 Phluid Corporation Company Overview
  • 5.15 Sensile Medical AG Company Overview
  • 5.16 SFC Fluidics LLC Company Overview
  • 5.17 Spring Health Solutions Ltd. Company Overview
  • 5.18 Tandem Diabetes Care Inc Company Overview
  • 5.19 Terumo Corp Company Overview
  • 5.20 Thermalin Inc Company Overview
  • 5.21 Univlabs Technologies Pvt Ltd Company Overview
  • 5.22 ViCentra BV Company Overview
  • 5.23 Ypsomed Holding AG Company Overview

6 Insulin Pumps- Recent Developments

  • 6.1 Jun 11, 2019: Changes in Roche's board of directors and corporate executive committee
  • 6.2 Jun 11, 2019: Regulators demand more details on Roche's $4.8bn Spark acquisition
  • 6.3 May 28, 2019: LifeScan names Alisandra Rizzolo Head of Transformation
  • 6.4 May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results
  • 6.5 May 23, 2019: Ypsomed increases EBIT and invests in long-term profitability
  • 6.6 May 20, 2019: ViCentra accelerates international expansion with appointment of new CEO
  • 6.7 May 20, 2019: LifeScan Names Ty Lee Head of Marketing
  • 6.8 May 09, 2019: Cellnovo announces the initiation of compulsory liquidation proceedings with cessation of business
  • 6.9 May 02, 2019: Insulet celebrates new global headquarters and U.S. manufacturing facility in Acton, MA
  • 6.10 May 02, 2019: Integer Holdings reports first quarter 2019 results
  • 6.11 May 02, 2019: Insulet Reports First Quarter 2019 Revenue of $159.6 Million, an Increase of 29% Year-Over-Year

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

  • Table 1: Insulin Pumps - Pipeline Products by Stage of Development
  • Table 2: Insulin Pumps - Pipeline Products by Segment
  • Table 3: Insulin Pumps - Pipeline Products by Territory
  • Table 4: Insulin Pumps - Pipeline Products by Regulatory Pa

List of Figures

  • Figure 1: Insulin Pumps - Pipeline Products by Stage of Development
  • Figure 2: Insulin Pumps - Pipeline Products by Segment
  • Figure 3: Insulin Pumps - Pipeline Products by Territory
  • Figure 4: Insulin Pumps - Pipeline Products by Regulato
Back to Top